{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:28:23Z","timestamp":1774679303472,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101142","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:08:10Z","timestamp":1772557690000},"page":"101142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer \u2013 results from a European multicenter cohort study"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3790-3278","authenticated-orcid":false,"given":"Sebastian","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabell","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-6332","authenticated-orcid":false,"given":"Lena","family":"K\u00e4stner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0636-4296","authenticated-orcid":false,"given":"Johannes","family":"Meents","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8591-5941","authenticated-orcid":false,"given":"Marek","family":"Slavik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-9376","authenticated-orcid":false,"given":"Petr","family":"Burkon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-3275","authenticated-orcid":false,"given":"Mauro","family":"Loi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-5208","authenticated-orcid":false,"given":"Pierluigi","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"von Wachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-6446","authenticated-orcid":false,"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Sabrina","family":"Schunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4116-0491","authenticated-orcid":false,"given":"Sophia","family":"Drabke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Holy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Klischies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-3139","authenticated-orcid":false,"given":"Olaf","family":"Wittenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4253-0627","authenticated-orcid":false,"given":"Jochen","family":"Willner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Baehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priska","family":"Bank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9132-012X","authenticated-orcid":false,"given":"Richard","family":"Partl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1834-7602","authenticated-orcid":false,"given":"Thomas","family":"Mader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Frerker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4043-7066","authenticated-orcid":false,"given":"Fabian","family":"Lohaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-4273","authenticated-orcid":false,"given":"Maike","family":"Trommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Gkika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-897X","authenticated-orcid":false,"given":"Alexander","family":"R\u00fchle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-2350","authenticated-orcid":false,"given":"Christos","family":"Moustakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6780-2820","authenticated-orcid":false,"given":"Thomas","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-1308","authenticated-orcid":false,"given":"Oliver","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit Boda-","family":"Heggemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2550-1410","authenticated-orcid":false,"given":"Nils H.","family":"Nicolay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"N\u00e4gler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctro.2026.101142_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ctro.2026.101142_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2018.10.004","article-title":"Metastatic bone disease: pathogenesis and therapeutic options: up-date on bone metastasis management","volume":"15","author":"D'Oronzo","year":"2019","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1392667","article-title":"Incidence and risk factors for bone metastases at presentation in solid tumors","volume":"14","author":"Knapp","year":"2024","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101142_b0020","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.radonc.2015.10.015","article-title":"Incidence and treatment patterns of complicated bone metastases in a population-based radiotherapy program","volume":"118","author":"Tiwana","year":"2016","journal-title":"Radiother Oncol"},{"issue":"20 Pt 2","key":"10.1016\/j.ctro.2026.101142_b0025","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2022.05.024","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases","volume":"173","author":"van der Velden","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0040","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1200\/JCO.23.00753","article-title":"Prophylactic radiation therapy versus standard of care for patients with high-risk asymptomatic bone metastases: a multicenter, randomized phase II clinical trial","volume":"42","author":"Gillespie","year":"2024","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101142_b0045","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","article-title":"Stereotactic radiation for the comprehensive treatment of oligometastases (SABR-COMET): extended long-term outcomes","volume":"114","author":"Harrow","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.ctro.2026.101142_b0050","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109966","article-title":"ESTRO clinical practice guideline: stereotactic body radiotherapy for spine metastases","volume":"190","author":"Guckenberger","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0060","article-title":"Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases","volume":"45","author":"Burgess","year":"2024","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110717","article-title":"Stereotactic body radiotherapy for non-spine bone metastases: a meta-analysis and international stereotactic radiosurgery society (ISRS) clinical practice guidelines","volume":"205","author":"Nguyen","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0070","doi-asserted-by":"crossref","unstructured":"Chmura SJ, Winter KA, Woodward WA, Borges VF, Salama JK, Al-Hallaq HA et al. NRG-BR002: A phase IIR\/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and\/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557). JCO;40(16_suppl):1007. https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.1007.","DOI":"10.1200\/JCO.2022.40.16_suppl.1007"},{"issue":"10422","key":"10.1016\/j.ctro.2026.101142_b0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ctro.2026.101142_b0080","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2022.10.017","article-title":"Stereotactic body radiation therapy versus conventional radiation therapy in pain relief for bone metastases: a systematic review and meta-analysis","volume":"115","author":"Song","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101142_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109914","article-title":"Stereotactic body radiation therapy versus conventional external beam radiotherapy for spinal metastases: a systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Wong","year":"2023","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2026.101142_b0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.55409","article-title":"Stereotactic body and conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis","volume":"7","author":"Bindels","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0095","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a european society for radiotherapy and oncology and european organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101142_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","article-title":"ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams","volume":"195","author":"Wilke","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ctro.2026.101142_b0105","unstructured":"Seuntjens J. ICRU Report 91: prescribing, recording, and reporting of stereotactic treatments with small photon beams. J ICRU;2014."},{"issue":"5","key":"10.1016\/j.ctro.2026.101142_b0110","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International spine radiosurgery consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13014-018-1040-z","article-title":"The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies","volume":"13","author":"van Leeuwen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101142_b0120","unstructured":"U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. Common Terminology Criteria for Adverse Events (CTCAE). [April 10, 2025]; Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf."},{"issue":"11","key":"10.1016\/j.ctro.2026.101142_b0125","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1634\/theoncologist.2018-0085","article-title":"Prognostic factors in patients with metastatic breast cancer with bone\u2010only metastases","volume":"23","author":"Parkes","year":"2018","journal-title":"Oncologist"},{"key":"10.1016\/j.ctro.2026.101142_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41523-018-0054-x","article-title":"Characterization of bone only metastasis patients with respect to tumor subtypes","volume":"4","author":"Parkes","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ctro.2026.101142_b0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2020.01.030","article-title":"Single fraction radiosurgery, fractionated radiosurgery, and conventional radiotherapy for spinal oligometastasis (SAFFRON): a systematic review and meta-analysis","volume":"146","author":"Singh","year":"2020","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(20)30537-4","article-title":"Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study","volume":"22","author":"Chalkidou","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2026.101142_b0145","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.eururo.2025.07.006","article-title":"Continuous androgen deprivation therapy with or without metastasis-directed therapy for oligometastatic prostate cancer: the multicenter phase 2 randomized EXTEND trial","volume":"88","author":"Sherry","year":"2025","journal-title":"Eur Urol"},{"issue":"5_suppl","key":"10.1016\/j.ctro.2026.101142_b0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2025.43.5_suppl.15","article-title":"World-wide oligometastatic prostate cancer (omPC) meta-analysis leveraging individual patient data (IPD) from randomized trials (WOLVERINE): an analysis from the X-MET collaboration","volume":"43","author":"Tang","year":"2025","journal-title":"JCO"},{"issue":"2","key":"10.1016\/j.ctro.2026.101142_b0155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4149\/neo_2018_180731N558","article-title":"Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study","volume":"66","author":"Burkon","year":"2019","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijrobp.2024.12.015","article-title":"Pulmonary stereotactic body radiation therapy of oligometastatic head-and-neck squamous cell carcinoma: a multicenter retrospective study","volume":"122","author":"N\u00e4gler","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101142_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100710","article-title":"Stereotactic body radiotherapy for spine and non-spine bone metastases in prostate carcinoma \u2013 a multicenter cohort analysis","author":"N\u00e4gler","year":"2025","journal-title":"J Bone Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12885-019-5362-5","article-title":"The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases","volume":"19","author":"Klement","year":"2019","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctro.2026.101142_b0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2024.10.030","article-title":"Adding metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic breast cancer (EXTEND): a multicenter, randomized phase 2 trial","volume":"121","author":"Reddy","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12885-020-06876-4","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 1\u20133 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial","volume":"20","author":"Olson","year":"2020","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0185","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101142_b0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.radonc.2018.11.022","article-title":"Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: some patients survive longer than a decade","volume":"131","author":"Milano","year":"2019","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.ctro.2026.101142_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092390","article-title":"Diagnosis and treatment of bone metastases in breast cancer: radiotherapy, local approach and systemic therapy in a guide for clinicians","volume":"12","author":"Marazzi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2017.08.032","article-title":"Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial","volume":"126","author":"Trovo","year":"2018","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0205","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s10555-024-10236-0","article-title":"Efficacy of innovative systemic treatments in combination with radiotherapy for bone metastases: a GEMO (the European Study Group of Bone Metastases) state of the art","volume":"44","author":"Gueiderikh","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ctro.2026.101142_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108280","article-title":"Therapeutics targeting the metastatic breast cancer bone microenvironment","volume":"239","author":"Ihle","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ctro.2026.101142_b0215","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41588-022-01041-y","article-title":"Breast tumor microenvironment structures are associated with genomic features and clinical outcome","volume":"54","author":"Danenberg","year":"2022","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.ctro.2026.101142_b0220","article-title":"The evolution of radiation therapy in metastatic breast cancer: from local therapy to systemic agent","volume":"2018","author":"Jutzy","year":"2018","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/j.ctro.2026.101142_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2025.100694","article-title":"Management of aromatase inhibitor-associated bone loss (AIBL) in women with hormone-sensitive breast cancer: an updated joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG","volume":"53","author":"Hadji","year":"2025","journal-title":"J Bone Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101142_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102850","article-title":"Osteolytic vs. osteoblastic metastatic lesion: computational modeling of the mechanical behavior in the human vertebra after screws fixation procedure","volume":"11","author":"Bianchi","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ctro.2026.101142_b0235","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2024.11.082","article-title":"Spine stereotactic body radiation therapy in geriatric patients: implications of age and dose on iatrogenic vertebral compression fracture risk","volume":"121","author":"Chan","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826000376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:24:31Z","timestamp":1774671871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826000376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"alternative-id":["S2405630826000376"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101142","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer \u2013 results from a European multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101142"}}